A phase II single-blind, randomized, placebo-controlled trial to study the efficacy and safety of Study Drug administered as adjunctive treatment to patients with acquired thrombotic thrombocytopenic purpura.
Explore related content and topics
Webinar
The Challenges of Patient Recruitment in Oncology Trials - Part 2
This is the second in a 3-part series on ”The Challenges of Patient Recruitment in Oncology Trials”, Senior Patient Recruitment Managers Tricia…
View Resource
Blog
What Does the Future of Childhood Cancer Treatment Look Like?
Now that the RACE for Children Act has come into effect, the drug development industry and patients and their families are optimistic—more drugs will…
Read Story
Blog
The Need for More Elderly Patients in Cancer Clinical Trials
Read Story
View all related content and resources for Oncology
Explore Insights